M Aach1, R C Meindl, J Geßmann, T A Schildhauer, M Citak, O Cruciger. 1. Abteilung für Rückenmarkverletzte, Chirurgische Universitätsklinik und Poliklinik, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Deutschland, mirko.aach@bergmannsheil.de.
Abstract
BACKGROUND: Mobile exoskeletons are increasingly being applied in the course of rehabilitation and provision of medical aids to patients with spinal cord injuries. OBJECTIVES AND METHODS: This article gives a description of the currently available exoskeletal systems and the clinical application including scientific and medical evidence, to derive recommendations regarding clinical practice of the various exoskeletons in the rehabilitation of patients with spinal cord injuries. RESULTS: The different systems represent a useful adjunct to the therapeutic regimen depending on the medical objectives. Posture-controlled exoskeletons in particular enable mobilization of patients with neurological gait disorders via direct motion support. In addition the neurologically controlled exoskeleton HAL® leads to functional improvements in patients with residual muscular functions in the chronic phase of spinal cord injury in terms of improved walking abilities subsequent to training. However, beneficial effects on bone density, bladder function and perfusion are conceivable but not yet adequately supported by evidence. Positive effects on spasticity and neuropathic pain are currently based only on case series or small clinical trials. CONCLUSION: Although exoskeletons are not yet an established tool in the treatment of spinal cord injuries, the systems will play a more important role in rehabilitation of patients with spinal cord injuries in the future. Neurologically controlled exoskeletons show beneficial effects in the treatment of acute and chronic spinal cord injuries and might therefore evolve to be a useful alternative to conventional locomotion training.
BACKGROUND: Mobile exoskeletons are increasingly being applied in the course of rehabilitation and provision of medical aids to patients with spinal cord injuries. OBJECTIVES AND METHODS: This article gives a description of the currently available exoskeletal systems and the clinical application including scientific and medical evidence, to derive recommendations regarding clinical practice of the various exoskeletons in the rehabilitation of patients with spinal cord injuries. RESULTS: The different systems represent a useful adjunct to the therapeutic regimen depending on the medical objectives. Posture-controlled exoskeletons in particular enable mobilization of patients with neurological gait disorders via direct motion support. In addition the neurologically controlled exoskeleton HAL® leads to functional improvements in patients with residual muscular functions in the chronic phase of spinal cord injury in terms of improved walking abilities subsequent to training. However, beneficial effects on bone density, bladder function and perfusion are conceivable but not yet adequately supported by evidence. Positive effects on spasticity and neuropathic pain are currently based only on case series or small clinical trials. CONCLUSION: Although exoskeletons are not yet an established tool in the treatment of spinal cord injuries, the systems will play a more important role in rehabilitation of patients with spinal cord injuries in the future. Neurologically controlled exoskeletons show beneficial effects in the treatment of acute and chronic spinal cord injuries and might therefore evolve to be a useful alternative to conventional locomotion training.
Authors: Ryan J Farris; Hugo A Quintero; Spencer A Murray; Kevin H Ha; Clare Hartigan; Michael Goldfarb Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2013-06-18 Impact factor: 3.802
Authors: Drew B Fineberg; Pierre Asselin; Noam Y Harel; Irina Agranova-Breyter; Stephen D Kornfeld; William A Bauman; Ann M Spungen Journal: J Spinal Cord Med Date: 2013-07 Impact factor: 1.985
Authors: Mirko Aach; Oliver Cruciger; Matthias Sczesny-Kaiser; Oliver Höffken; Renate Ch Meindl; Martin Tegenthoff; Peter Schwenkreis; Yoshiyuki Sankai; Thomas A Schildhauer Journal: Spine J Date: 2014-04-04 Impact factor: 4.166
Authors: Lars Ung; Malte Ohlmeier; Birger Jettkant; Dennis Grasmücke; Mirko Aach; Renate Meindl; Volkmar Nicolas; Thomas A Schildhauer; Mustafa Citak Journal: Global Spine J Date: 2019-08-19
Authors: Christian Fisahn; Mirko Aach; Oliver Jansen; Marc Moisi; Angeli Mayadev; Krystle T Pagarigan; Joseph R Dettori; Thomas A Schildhauer Journal: Global Spine J Date: 2016-11-03
Authors: Oliver Jansen; Thomas A Schildhauer; Renate C Meindl; Martin Tegenthoff; Peter Schwenkreis; Matthias Sczesny-Kaiser; Dennis Grasmücke; Christian Fisahn; Mirko Aach Journal: Global Spine J Date: 2017-07-07